In order to confirm the aforementioned results obtained in yeast and NCM460 cells, we used cell lines derived from CRC patients and assessed whether suppression of KRAS affects autophagy levels in HCT116 (KRASG13D) and SW480 (KRASG12V) cells. This evidence concerns the gene KRAS and colorectal carcinoma.